Alison Looby

1.2k total citations
67 papers, 802 citations indexed

About

Alison Looby is a scholar working on Psychiatry and Mental health, Epidemiology and Pharmacology. According to data from OpenAlex, Alison Looby has authored 67 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Psychiatry and Mental health, 26 papers in Epidemiology and 25 papers in Pharmacology. Recurrent topics in Alison Looby's work include Attention Deficit Hyperactivity Disorder (26 papers), Substance Abuse Treatment and Outcomes (26 papers) and Neuroethics, Human Enhancement, Biomedical Innovations (18 papers). Alison Looby is often cited by papers focused on Attention Deficit Hyperactivity Disorder (26 papers), Substance Abuse Treatment and Outcomes (26 papers) and Neuroethics, Human Enhancement, Biomedical Innovations (18 papers). Alison Looby collaborates with scholars based in United States and Canada. Alison Looby's co-authors include Mitch Earleywine, Tess M. Kilwein, Adrián J. Bravo, Kyle P. De Young, Scott E. Lukas, David M. Penetar, Elizabeth Ryan, Margo C. Hurlocker, Ty S. Schepis and Zhaohui Su and has published in prestigious journals such as Clinical Psychology Review, Drug and Alcohol Dependence and Journal of Psychiatric Research.

In The Last Decade

Alison Looby

61 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Looby United States 17 275 252 249 217 174 67 802
Laura M. Garnier-Dykstra United States 14 226 0.8× 301 1.2× 232 0.9× 284 1.3× 274 1.6× 14 911
Jasmine Turna Canada 17 384 1.4× 158 0.6× 346 1.4× 100 0.5× 93 0.5× 30 976
Fermín Fernández‐Calderón Spain 17 126 0.5× 326 1.3× 343 1.4× 207 1.0× 93 0.5× 80 883
Golfo K. Tzilos United States 15 192 0.7× 191 0.8× 137 0.6× 103 0.5× 189 1.1× 27 796
Maeve O’Leary-Barrett Canada 11 127 0.5× 296 1.2× 429 1.7× 144 0.7× 71 0.4× 15 814
Deborah Deas United States 16 95 0.3× 318 1.3× 407 1.6× 240 1.1× 104 0.6× 30 986
Suzette Glasner‐Edwards United States 15 163 0.6× 358 1.4× 434 1.7× 261 1.2× 105 0.6× 21 1.2k
Sarah L. Pedersen United States 19 154 0.6× 532 2.1× 410 1.6× 251 1.2× 191 1.1× 68 1.3k
Adam C. Brooks United States 12 138 0.5× 267 1.1× 149 0.6× 174 0.8× 146 0.8× 22 826
Katherine A. Belendiuk United States 14 189 0.7× 129 0.5× 239 1.0× 175 0.8× 105 0.6× 22 573

Countries citing papers authored by Alison Looby

Since Specialization
Citations

This map shows the geographic impact of Alison Looby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Looby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Looby more than expected).

Fields of papers citing papers by Alison Looby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Looby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Looby. The network helps show where Alison Looby may publish in the future.

Co-authorship network of co-authors of Alison Looby

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Looby. A scholar is included among the top collaborators of Alison Looby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Looby. Alison Looby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braitman, Abby L., et al.. (2025). Check your data before you wreck your model: The impact of careless responding on substance use data quality. Alcohol Clinical and Experimental Research. 49(4). 941–951. 1 indexed citations
2.
Holt, Laura J., Alison Looby, Richard Feinn, & Ty S. Schepis. (2025). Preventing Prescription Stimulant Diversion and Misuse via a Web-Based Intervention: A Randomized Controlled Trial. PsyArXiv (OSF Preprints).
3.
Looby, Alison, et al.. (2024). “If You Don’t Eat, You Can Get Drunk Faster”: A Qualitative Investigation of Food and Alcohol Disturbance (FAD) Expectancies. Substance Use & Misuse. 59(11). 1647–1655. 2 indexed citations
4.
5.
Holt, Laura J., et al.. (2022). Sources for prescription stimulant misuse: A person-centered approach to understanding links to substance use and psychiatric impairment.. Experimental and Clinical Psychopharmacology. 31(2). 498–506. 2 indexed citations
6.
Lefler, Elizabeth K., et al.. (2022). Sex differences in ADHD symptoms, problematic gaming, and impairment in college students. Current Psychology. 42(30). 26836–26847. 4 indexed citations
7.
Bravo, Adrián J., et al.. (2022). Negative Affect Regulation and Marijuana Use in College Students: Evaluating the Mediating Roles of Coping and Sleep Motives. Journal of Psychoactive Drugs. 55(2). 203–212. 5 indexed citations
8.
9.
Kilwein, Tess M. & Alison Looby. (2021). Sex-related impelling cues uniquely predict event-level alcohol-related sexual behavior that poses heightened risk for negative consequences among college women.. Experimental and Clinical Psychopharmacology. 30(6). 853–861. 2 indexed citations
10.
Looby, Alison, et al.. (2021). Expectation for stimulant type modifies caffeine’s effects on mood and cognition among college students.. Experimental and Clinical Psychopharmacology. 30(5). 525–535. 3 indexed citations
11.
Looby, Alison, Mark A. Prince, Margo C. Hurlocker, et al.. (2021). Young adult use, dual use, and simultaneous use of alcohol and marijuana: An examination of differences across use status on marijuana use context, rates, and consequences.. Psychology of Addictive Behaviors. 35(6). 682–690. 37 indexed citations
12.
Looby, Alison, Mark A. Prince, Elizabeth K. Lefler, et al.. (2021). Relations among protective behavioral strategies, biological sex, and ADHD symptoms on alcohol use and related problems: Who benefits most, and from what type of strategy?. Addictive Behaviors. 119. 106924–106924. 9 indexed citations
13.
Holt, Laura J., et al.. (2019). How to say “no” most effectively: Evaluating resistance strategies for prescription stimulant diversion to inform preventive interventions. Journal of American College Health. 68(8). 872–882. 4 indexed citations
14.
15.
Sargent, Emily, Tess M. Kilwein, Robert D. Dvorak, et al.. (2018). Deviance regulation theory and drinking outcomes among Greek-life students during spring break.. Experimental and Clinical Psychopharmacology. 26(4). 366–376. 10 indexed citations
16.
Looby, Alison, et al.. (2018). Nonmedical prescription stimulant users experience subjective but not objective impairments in attention and impulsivity. American Journal on Addictions. 27(3). 238–244. 6 indexed citations
17.
Young, Kyle P. De, et al.. (2016). The Role of Anonymity in Determining the Self-Reported Use of Cocaine and Nonmedical Prescription Stimulant Use Among College Students. Substance Use & Misuse. 51(7). 795–802. 5 indexed citations
18.
Looby, Alison & Mitch Earleywine. (2011). Expectation to receive methylphenidate enhances subjective arousal but not cognitive performance.. Experimental and Clinical Psychopharmacology. 19(6). 433–444. 49 indexed citations
19.
Lavender, Jason M., Alison Looby, & Mitch Earleywine. (2008). A brief cannabis‐associated problems questionnaire with less potential for bias. Human Psychopharmacology Clinical and Experimental. 23(6). 487–493. 17 indexed citations
20.
Looby, Alison & Mitch Earleywine. (2007). The impact of methamphetamine use on subjective well‐being in an Internet survey: preliminary findings. Human Psychopharmacology Clinical and Experimental. 22(3). 167–172. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura M. Garnier-Dykstra Breakdown of academic impact, for papers by Jasmine Turna Breakdown of academic impact, for papers by Fermín Fernández‐Calderón Breakdown of academic impact, for papers by Golfo K. Tzilos Breakdown of academic impact, for papers by Maeve O’Leary-Barrett Breakdown of academic impact, for papers by Deborah Deas Breakdown of academic impact, for papers by Suzette Glasner‐Edwards Breakdown of academic impact, for papers by Sarah L. Pedersen Breakdown of academic impact, for papers by Adam C. Brooks Breakdown of academic impact, for papers by Katherine A. Belendiuk
Rankless by CCL
2026